Page last updated: 2024-09-05

opc 28326 and phenylephrine

opc 28326 has been researched along with phenylephrine in 1 studies

Compound Research Comparison

Studies
(opc 28326)
Trials
(opc 28326)
Recent Studies (post-2010)
(opc 28326)
Studies
(phenylephrine)
Trials
(phenylephrine)
Recent Studies (post-2010) (phenylephrine)
91113,7978572,083

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiki, H; Imaizumi, T; Kambayashi, J; Kimura, Y; Kishi, M; Mori, T; Orito, K; Shimizu, H; Tanaka, M; Teramoto, S; Tominaga, M; Yoshida, K1

Other Studies

1 other study(ies) available for opc 28326 and phenylephrine

ArticleYear
Mechanisms of action of OPC-28326, a selective hindlimb vasodilator.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:2

    Topics: Adrenergic Antagonists; Anesthesia; Aniline Compounds; Animals; Blood Pressure; Brimonidine Tartrate; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Femoral Artery; Hemodynamics; Hindlimb; In Vitro Techniques; Male; Perfusion; Phenylephrine; Piperidines; Prazosin; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Vasodilator Agents; Yohimbine

1999